Browsing: Patients

AT A GLANCE: Crohn’s disease is a condition that can affect any part of the digestive system. While it affects people throughout their lives in different ways, more treatment options are now available. Physicians are also finding promising lifestyle adjustments to help with the disease. Here are five things you will learn about Crohn’s disease from Sowmya…

Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds especially well to tirzepatide, a medication that mimics two naturally occurring hormones involved in appetite and blood sugar regulation, moving the…

Setmelanotide, a melanocortin-4 receptor agonist, significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The New England Journal of Medicine. Although focused primarily on patients with craniopharyngioma, this study addresses a clinically important survivorship issue: the management of…